Business segment information (Tables)

12 Months Ended

Dec. 31, 2011

Business segment information

Business segments by GBU

	Year ended December 31, (US$ in thousands)
	2011				2010				2009
	Net Sales		Percent of Total Net Sales		Net Sales		Percent of Total Net Sales		Net Sales		Percent of Total Net Sales
Spine	$	304,217	52	%	$	306,404	54	%	$	279,425	51	%
Orthopedics	165,904		29	%	154,198		27	%	151,054		28	%
Sports Medicine	108,867		19	%	103,768		19	%	115,156		21	%
Total Net Sales	$	578,988	100	%	$	564,370	100	%	$	545,635	100	%

Market sectors

	Year ended December 31, (US$ in thousands)
	2011				2010				2009
	Net Sales		Percent of Total Net Sales		Net Sales		Percent of Total Net Sales		Net Sales		Percent of Total Net Sales
Spine Products
Implants and Biologics	$	143,775	24	%	$	133,831	23	%	$	120,445	22	%
Stimulation	160,442		28	%	172,573		31	%	158,980		29	%
Total Spine Products	304,217		52	%	306,404		54	%	279,425		51	%
Orthopedics Products	165,904		29	%	149,175		26	%	139,304		25	%
Sports Medicine Products	103,040		18	%	95,514		18	%	96,446		18	%
Total Strategic Products	573,161		99	%	551,093		98	%	515,175		94	%
Divested Products	5,827		1	%	13,277		2	%	30,460		6	%
Total Net Sales	$	578,988	100	%	$	564,370	100	%	$	545,635	100	%

Operating income (loss) by GBU

Operating Income (Loss)	Year Ended December 31,
(US$ in thousands)	2011			2010			2009
Spine (1)	$	46,618		$	80,688		$	60,830
Orthopedics (2)	12,368			5,879			5,781
Sports Medicine (3)	1,166			22,586			21,347
Corporate (4)	(27,633		)	(20,163		)	(24,083		)
Total	$	32,519		$	88,990		$	63,875

(1)	For 2011, the operating income for the Spine GBU included $42.5 million of expenses in connection with charges related to U.S. Government resolutions.
(2)	For 2011, the operating income for the Orthopedics GBU included $6.5 million of expenses in connection with charges related to U.S. Government resolutions.
(3)	For 2011, the operating income for the Sports Medicine GBU included $5 million of litigation and settlement costs for certain product liability matters related to our Sports Medicine GBU.  For 2011, the operating income for the Sports Medicine GBU included $2 million of insurance expense to cover additional product liability claims related to our Sports Medicine GBU.  For 2010, the operating income for the Sports Medicine GBU included $12 million from the net gain on sale of vascular operations.  For 2010, the operating income for the Sports Medicine GBU included $1.7 million of insurance expense to cover new product liability claims from its former pain management operations sold in 2008.
(4)	For 2011, the operating loss for the Corporate GBU included $7.5 million of expenses in connection with charges related to U.S. Government inquiries and $3.2 million of senior management succession charges.

Selected financial information by reporting segment

	Depreciation and amortization
(US$ in thousands)	2011		2010		2009
Spine	$	11,060	$	9,407	$	9,154
Orthopedics	5,506		6,282		5,733
Sports Medicine	6,158		6,706		7,348
Corporate	52		126		109
Total	$	22,776	$	22,521	$	22,344

Analysis of property, plant and equipment of reporting segments by geographic area

(US$ in thousands)	2011		2010
U.S.	$	39,563	$	32,718
Italy	7,663		7,614
U.K.	1,449		1,618
Brazil	2,532		2,400
Others	917		1,185
Total	$	52,124	$	45,535